NFE2L2 and head and neck squamous cell carcinoma: To further assess the role of Nrf2 in chemotherapeutic resistance, we compared Nrf2 target genes in cisplatin sensitive (n = 6) and resistant (n = 6) HNSCC patients’ tumor cells by real-time quantitative polymerase chain reaction (qRT-PCR).